Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 22.46% ...
International diabetes pioneers and thought leaders from 11 countries will work with Biomea leadership to unlock the potential of menin science and beta cell biology to advance BMF-219 and Biomea’s ...
On Thursday, Biomea Fusion Inc (BMEA) stock saw a modest uptick, ending the day at $9.57 which represents a slight increase of $0.80 or 9.12% from the prior close of $8.77. The stock opened at $8.98 ...
BiomeaFusion (NASDAQ:BMEA – Get Free Report) was upgraded by stock analysts at Rodman & Renshaw from a “neutral” rating to a “buy” rating in a research note issued on Thursday ...
Results that may be inaccessible to you are currently showing.